Table 2.
The clinical information and sample size for TCGA LUSC dataset.
| Alive (n = 343) | Dead (n = 161) | Total (n = 504) | P Value | |
|---|---|---|---|---|
| Gender | ||||
| Female | 90 (26.2%) | 41 (25.5%) | 131 (26.0%) | |
| Male | 253 (73.8%) | 120 (74.5%) | 373 (74.0%) | 0.94 |
| Age | ||||
| Mean (SD) | 66.6 (8.5) | 68.7 (8.6) | 67.3 (8.6) | |
| Median [Min, Max] | 68 [39, 84] | 70 [40, 90] | 68 [39, 90] | |
| Race | ||||
| Asian | 6 (2.2%) | 3 (2.4%) | 9 (2.3%) | |
| Black Or African American | 14 (5.2%) | 17 (13.8%) | 31 (7.9%) | |
| White | 248 (92.5%) | 103 (83.7%) | 351 (89.8%) | 0.013 |
| Stage | ||||
| Stage IA | 69 (25.7%) | 21 (17.1%) | 90 (23.0%) | |
| Stage IB | 100 (37.3%) | 52 (42.3%) | 152 (38.9%) | |
| Stage II | 1 (0.4%) | 2 (1.6%) | 3 (0.\%) | |
| Stage IIA | 53 (19.8%) | 12 (9.8%) | 65 (16.6%) | |
| Stage IIB | 65 (24.3%) | 30 (24.4%) | 95 (24.3%) | |
| Stage IIIA | 40 (14.9%) | 23 (18.7%) | 63 (16.1%) | |
| Stage IIIB | 9 (3.4%) | 10 (8.1%) | 19 (4.9%) | |
| Stage IV | 4 (1.5%) | 3 (2.4%) | 7 (1.8%) | |
| Stage I | 3 (2.4%) | 3 (0.8%) | ||
| Stage III | 3 (2.4%) | 3 (0.8%) | 0.095 | |